Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylephrine Gel for IPAA-Related Faecal Incontinence
NCT00420797Phase 3Withdrawn
- Sponsor
- SLA Pharma
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in fecal incontinence (FI) comparing 10% Phenylephrine Gel with Placebo (2 arms). Primary endpoint: Change from baseline to the end of study in the faecal incontinence score (St Mark's) at 8 weeks. Planned start Feb 2007; status: withdrawn.
02
Drugs
phenylephrine
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on NCT00420797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420797.